In vitro studies of aculeacin A, a new antifungal antibiotic

28Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Aculeacin A is a cyclopeptide-containing long-chain fatty acid, representing a new class of antibiotics. It has a relatively narrow antifungal spectrum in vitro and is highly active against some groups of yeasts. Of 31 strains of Candida and Torulopsis tested, the majority were susceptible to aculeacin A at 0.31 μg per ml or less. On the other hand, the antibiotic was scarcely active or inactive against other yeasts, such as Cryptococcus neoformans, and all filamentous and dimorphic fungi tested. A distinct inoculum effect has been observed in vitro with a number of strains of C. albicans minimum growth-inhibitory concentrations (MIC) have tended to increase with increased incubationtime. MIC values were also increased in the presence of serum. Aculeacin A is fungicidal for growing cells of C. albicans. It was most lethal against sensitive yeasts at 0.08 to 0.31 pg per ml, and increases in the concentration of the drug above this range reduced, rather than increased, its lethal effect. © 1982, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Iwata, K., Yamamoto, Y., Yamaguchi, H., & Hiratani, T. (1982). In vitro studies of aculeacin A, a new antifungal antibiotic. The Journal of Antibiotics, 35(2), 203–209. https://doi.org/10.7164/antibiotics.35.203

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free